Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.

Saved in:
Bibliographic Details
Title: Monoclonal Antibodies for Migraine Prevention: Progress, but Not a Panacea.
Authors: Loder EW; Division of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Robbins MS; Jack D. Weiler Hospital, Montefiore Medical Center, Inpatient Services, Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, New York.
Source: JAMA [JAMA] 2018 May 15; Vol. 319 (19), pp. 1985-1987.
Publication Type: Editorial; Comment
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1538-3598
DOI:10.1001/jama.2018.4852